evertex fabrinology Crescita futura

Future criteri di controllo 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for evertex fabrinology.

Informazioni chiave

n/a

Tasso di crescita degli utili

n/a

Tasso di crescita dell'EPS

Luxury crescita degli utili	14.2%
Tasso di crescita dei ricavi	n/a
Rendimento futuro del capitale proprio	n/a
Copertura analitica	None
Ultimo aggiornamento	n/a

Aggiornamenti recenti sulla crescita futura

Nessun aggiornamento

Recent updates

evertex fabrinology limited's (TWSE:1470) Business Is Yet to Catch Up With Its Share Price

Sep 16

evertex fabrinology's (TWSE:1470) Profits May Not Reveal Underlying Issues

Mar 20

Does evertex fabrinology limited (TPE:1470) Have A Place In Your Dividend Stock Portfolio?

Apr 25

Be Wary Of evertex fabrinology (TPE:1470) And Its Returns On Capital

Mar 26

evertex fabrinology limited's (TPE:1470) Financial Prospects Don't Look Very Positive: Could It Mean A Stock Price Drop In The Future?

Mar 05

Does evertex fabrinology's (TPE:1470) Statutory Profit Adequately Reflect Its Underlying Profit?

Feb 12

Tread With Caution Around evertex fabrinology limited's (TPE:1470) 4.6% Dividend Yield

Jan 25

Would Shareholders Who Purchased evertex fabrinology's (TPE:1470) Stock Year Be Happy With The Share price Today?

Jan 07

Is evertex fabrinology (TPE:1470) Headed For Trouble?

Dec 20

evertex fabrinology limited's (TPE:1470) Financial Prospects Don't Look Very Positive: Could It Mean A Stock Price Drop In The Future?

Dec 02

In questa sezione di solito presentiamo le proiezioni di crescita dei ricavi e degli utili basate sulle stime di consenso degli analisti professionisti per aiutare gli investitori a capire la capacità della società di generare profitti. Tuttavia, poiché evertex fabrinology non ha fornito dati sufficienti sul passato e non ha previsioni degli analisti, i suoi utili futuri non possono essere calcolati in modo affidabile estrapolando i dati passati o utilizzando le previsioni degli analisti.

Si tratta di una situazione piuttosto rara, dato che il 97% delle società coperte da SimplyWall St dispone di dati finanziari passati.

Previsioni di crescita degli utili e dei ricavi

TWSE:1470 - Stime future degli analisti e dati finanziari passati (TWD Millions )
Data	Ricavi	Guadagni	Flusso di cassa libero	Liquidità dell'operazione	Avg. Numero di analisti
6/30/2024	651	60	74	97	N/A
3/31/2024	613	45	110	145	N/A
12/31/2023	655	49	111	145	N/A
9/30/2023	637	49	110	141	N/A
6/30/2023	717	56	183	206	N/A
3/31/2023	777	41	182	211	N/A
12/31/2022	845	33	162	189	N/A
9/30/2022	951	50	201	237	N/A
6/30/2022	968	50	88	128	N/A
3/31/2022	993	86	47	80	N/A
12/31/2021	895	65	-1	44	N/A
9/30/2021	858	67	-30	6	N/A
6/30/2021	773	63	-33	18	N/A
3/31/2021	626	25	-24	36	N/A
12/31/2020	631	35	17	76	N/A
9/30/2020	647	32	27	94	N/A
6/30/2020	695	40	73	132	N/A
3/31/2020	815	72	71	119	N/A
12/31/2019	818	76	58	94	N/A
9/30/2019	814	79	58	93	N/A
6/30/2019	802	77	34	76	N/A
3/31/2019	792	62	47	98	N/A
12/31/2018	754	49	37	106	N/A
9/30/2018	735	47	3	99	N/A
6/30/2018	704	36	-31	91	N/A
3/31/2018	693	40	N/A	89	N/A
12/31/2017	701	42	N/A	99	N/A
9/30/2017	711	42	N/A	107	N/A
6/30/2017	703	39	N/A	104	N/A
3/31/2017	682	40	N/A	113	N/A
12/31/2016	686	47	N/A	122	N/A
9/30/2016	687	50	N/A	127	N/A
6/30/2016	713	64	N/A	136	N/A
3/31/2016	745	62	N/A	99	N/A
12/31/2015	762	61	N/A	87	N/A
9/30/2015	770	63	N/A	77	N/A
6/30/2015	747	54	N/A	70	N/A
3/31/2015	743	62	N/A	76	N/A
12/31/2014	744	66	N/A	91	N/A
9/30/2014	738	57	N/A	67	N/A
6/30/2014	748	58	N/A	83	N/A
3/31/2014	707	42	N/A	120	N/A
12/31/2013	669	29	N/A	113	N/A

Previsioni di crescita futura degli analisti

Guadagni vs tasso di risparmio: Insufficient data to determine if 1470's forecast earnings growth is above the savings rate (1%).

Guadagni vs Mercato: Insufficient data to determine if 1470's earnings are forecast to grow faster than the TW market

Guadagni ad alta crescita: Insufficient data to determine if 1470's earnings are expected to grow significantly over the next 3 years.

Ricavi vs Mercato: Insufficient data to determine if 1470's revenue is forecast to grow faster than the TW market.

Ricavi ad alta crescita: Insufficient data to determine if 1470's revenue is forecast to grow faster than 20% per year.

Previsioni di crescita dell'utile per azione

Rendimento futuro del capitale proprio

ROE futuro: Insufficient data to determine if 1470's Return on Equity is forecast to be high in 3 years time

evertex fabrinology Crescita futura

Future criteri di controllo 0/6

Informazioni chiave

Aggiornamenti recenti sulla crescita futura

Recent updates

evertex fabrinology limited's (TWSE:1470) Business Is Yet to Catch Up With Its Share Price

Investor sentiment improves as stock rises 16%

Second quarter 2024 earnings released: EPS: NT$0.27 (vs NT$0.10 in 2Q 2023)

evertex fabrinology limited to Report Q2, 2024 Results on Aug 09, 2024

Upcoming dividend of NT$0.58 per share

First quarter 2024 earnings released: EPS: NT$0.36 (vs NT$0.41 in 1Q 2023)

Dividend increased to NT$0.58

Evertex Fabrinology Ltd. Announces Cash Dividend, Payable on August 16, 2024

evertex fabrinology limited to Report Q1, 2024 Results on May 10, 2024

evertex fabrinology's (TWSE:1470) Profits May Not Reveal Underlying Issues

Full year 2023 earnings released: EPS: NT$0.58 (vs NT$0.38 in FY 2022)

evertex fabrinology limited, Annual General Meeting, Jun 25, 2024

Third quarter 2023 earnings released: EPS: NT$0.06 (vs NT$0.15 in 3Q 2022)

Second quarter 2023 earnings released: EPS: NT$0.10 (vs NT$0.071 loss in 2Q 2022)

Upcoming dividend of NT$0.45 per share at 2.3% yield

Full year 2022 earnings released: EPS: NT$0.38 (vs NT$0.76 in FY 2021)

Less than half of directors are independent

Second quarter 2022 earnings released: NT$0.07 loss per share (vs NT$0.34 profit in 2Q 2021)

Upcoming dividend of NT$0.80 per share

Investor sentiment improved over the past week

First quarter 2022 earnings released: EPS: NT$0.31 (vs NT$0.076 in 1Q 2021)

Less than half of directors are independent

Investor sentiment improved over the past week

Full year 2021 earnings released: EPS: NT$0.76 (vs NT$0.41 in FY 2020)

Third quarter 2021 earnings released: EPS NT$0.15 (vs NT$0.11 in 3Q 2020)

Second quarter 2021 earnings released: EPS NT$0.34 (vs NT$0.11 loss in 2Q 2020)

Upcoming dividend of NT$0.42 per share

Does evertex fabrinology limited (TPE:1470) Have A Place In Your Dividend Stock Portfolio?

Full year 2020 earnings released: EPS NT$0.41 (vs NT$0.89 in FY 2019)

Be Wary Of evertex fabrinology (TPE:1470) And Its Returns On Capital

evertex fabrinology limited's (TPE:1470) Financial Prospects Don't Look Very Positive: Could It Mean A Stock Price Drop In The Future?

Does evertex fabrinology's (TPE:1470) Statutory Profit Adequately Reflect Its Underlying Profit?

Tread With Caution Around evertex fabrinology limited's (TPE:1470) 4.6% Dividend Yield

New 90-day low: NT$17.55

Would Shareholders Who Purchased evertex fabrinology's (TPE:1470) Stock Year Be Happy With The Share price Today?

Is evertex fabrinology (TPE:1470) Headed For Trouble?

evertex fabrinology limited's (TPE:1470) Financial Prospects Don't Look Very Positive: Could It Mean A Stock Price Drop In The Future?

Third quarter 2020 earnings released: EPS NT$0.11

New 90-day low: NT$17.50

New 90-day low - NT$17.75

First half earnings released

Upcoming Dividend of NT$0.80 Per Share

Previsioni di crescita degli utili e dei ricavi

Previsioni di crescita futura degli analisti

Previsioni di crescita dell'utile per azione

Rendimento futuro del capitale proprio

Scoprire le aziende in crescita